Press release
Angiotensin Receptor Blockers (ARBs) Market 2023 : Trends, Business Growth And Major Driving Factors | Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GSK Plc
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032Angiotensin Receptor Blockers (ARBs) Market Size, Growth Rate, And Forecast
The global angiotensin receptor blockers (ARBs) market size is expected to grow from $8.02 billion in 2022 to $8.30 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global angiotensin receptor blockers (ARBs) market size is expected to grow to $9.40 billion in 2027 at a CAGR of 3.2%.
Get A Free Sample Report Link
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
Angiotensin Receptor Blockers (ARBs) Market Drivers
The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. By assisting in vein and artery relaxation, angiotensin receptor blockers lower blood pressure and facilitate the heart's ability to pump blood, which can reduce cardiovascular diseases.
Learn More On The Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
Angiotensin Receptor Blockers (ARBs) Market Segments
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Angiotensin Receptor Blockers (ARBs) market.
Check Out Buying Options For The Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
Angiotensin Receptor Blockers (ARBs) Market Key Players
Major players in the angiotensin receptor blockers (arbs) market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GSK Plc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., Lupin Pharmaceuticals Inc., Astellas Pharma Inc., and Boehringer Ingelheim Ltd.
The Business Research Company's "Global Angiotensin Receptor Blockers (ARBs) Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.
The Table Of Content For The Angiotensin Receptor Blockers (ARBs) Market Include:
1. Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Characteristics
3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies
4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario
5. Angiotensin Receptor Blockers (ARBs) Market Size And Growth
……
27. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market
29. Angiotensin Receptor Blockers (ARBs) Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market 2023 : Trends, Business Growth And Major Driving Factors | Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GSK Plc here
News-ID: 3029880 • Views: …
More Releases from The Business research company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for ARBs
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market Current Status and Future Prospects …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key…
Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $10.28 billion In…
Angiotensin Receptor Blockers (ARBs) Market size, Share, Trends, Drivers And For …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Angiotensin Receptor Blockers (ARBs) Global Market Report 2023 identifies the increasing incidence of cardiovascular diseases as the major driver for the angiotensin receptor blockers (ARBs) market's growth in the forecast period. It is frequently associated with the development of fatty deposits within the…
Angiotensin Receptor Blockers (Arbs) Market Size, Share, Growth Report 2023
The global angiotensin receptor blockers (arbs) market size was valued at USD 8,049.9 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. The primary drivers of the expansion of the global angiotensin receptor blockers market include the increasing prevalence of cardiovascular diseases and chronic kidney disorders. In addition, increasing geriatric population is expected to boost the growth of angiotensin receptor…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
